26816 Federal Register / Vol. 63, No. 93 /Thursday, May 14, 1998 / Notices

the data collection plans and

instruments, contact Michael C.R.

Alavanja, Dr. P.H., Epidemiology and

Biostatistics Program, Division of

Cancer Etiology, National Cancer

Institute, EPN 418, 6130 Executive

Boulevard, Rockville, MD 20852, or call

(310) 496–9093, or E-mail your request,

including your address to:

alavanjam@epndce.nci.nih.gov

COMMENTS DUE DATE: Comments

regarding this information collection are

best assured of having their full effect if

received on or before July 13, 1998.

Date: May 6, 1998.

Reesa Nichols,

OMB Project Clearance Liaison.

[FR Doc. 98–12778 Filed 5–17–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Notice of Meeting of the Advisory

Committee to the Director, NIH

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Advisory Committee to the Director,

NIH, June 4, 1998, Conference Room 10,

Building 31, National Institutes of

Health, Bethesda, Maryland 20892.

The entire meeting will be open to the

public from 9:00 a.m. to adjournment.

The topics proposed for discussion

include: (1) Enhancing Diversity in

Biomedical Research at NIH; (2)

Bioengineering Conference: (3) Report

from the Working Group on Research

Tools; (4) Bioethics; and (5) DHHS

Report on Research Misconduct.

Attendance by the public will be limited

to space available.

Ms. Janice Ramsden, Special Assistant

to the Deputy Director, National

Institutes of Health, 1 Center Drive MSC

0159, Bethesda, Maryland 20892–0159,

telephone (301) 496–0959, fax (301)

496–7451, will furnish the meeting

agenda, roster of committee members,

and available substantive program

information upon request. Any

individual who requires special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Ramsden no later than May 29, 1998.

Dated: May 6, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12774 Filed 5–13–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meetings in conjunction with the

National Institute of Dental Research

and the National Institute of Arthritis

and Musculoskeletal and Skin Diseases.

Name of SEP: Nutrition Academic Awards.

Date: June 10–11, 1998.

Time: 9:00 a.m.

Place: Holiday Inn Chevy Chase, 5520

Wisconsin Avenue, Bethesda, Maryland

20815.

Contact Person: Louise Corman, Ph.D.,

Two Rockledge Center, Room 7180, 6701

Rockledge Drive, Bethesda, Maryland 20892–

7924, (301) 435–0270.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: National Food and Nutrient

Analysis Program—Interagency Agreement

Protocol.

Date: June 12, 1998.

Time: 9:30 a.m.

Place: Bethesda Ramada Inn, 8400

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Abby Ershow, M.D. Two

Rockledge Center, Room 9186, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0526.

Purpose/Agenda: To review and evaluate

an Interagency Agreement Protocol.

Name of SEP: Heart Failure Research: New

Approaches to Pathogenesis—NHLBI/NIA.

Date: June14–16, 1998.

Time: 7:00 p.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, Maryland 20814.

Contact Person: Diane M. Reid, M.D., Two

Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with provisions set forth in

sections 552b(c)(4) and 552b(c)(b), Title 5

U.S.C. Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: May 5, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12771 Filed 5–13–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Heart, Lung, and Blood

Institute Special Emphasis Panel (SEP)

meetings:

Name of SEP: Endothelial Dysfunction in

HIV Infection.

Date: June 9–10, 1998.

Time: 7:00 p.m.

Place: Holiday Inn Gaithersburg, 2

Montgomery Village Avenue, Gaithersburg,

Maryland 20879.

Contact Person: Ramesh Vemuri, Ph.D.,

Two Rockledge Center, Room 7194, 6701

Rockledge Drive, Bethesda, Maryland 20892–

7924, (301) 435–0476.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Molecular and Physical

Characterization of the Vulnerable Plaque.

Date: June 17–18, 1998.

Time: 7:00 p.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, Maryland 20814.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, Maryland 20892–

7924, (301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth in

secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: May 7, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–12776 Filed 5–13–98; 8:45 am]

BILLING CODE 4140–01–M